Nektar Therapeutics (NKTR) EBT Margin Growth (3y) (2013 - 2026)
Nektar Therapeutics (NKTR) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,237.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 363.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Nektar Therapeutics | 2.04 Bn | 1.48 Bn | 3.16 Mn | 23,807.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23,807.00 |
| Dec 31, 2025 | 9,762.00 |
| Sep 30, 2025 | -4,644.00 |
| Jun 30, 2025 | 38,395.00 |
| Mar 31, 2025 | -7,964.00 |
| Dec 31, 2024 | -149,062.00 |
| Sep 30, 2024 | 36,645.00 |
| Jun 30, 2024 | 21,907.00 |
| Mar 31, 2024 | 34,939.00 |
| Dec 31, 2023 | 32,270.00 |
| Sep 30, 2023 | 17,138.00 |
| Jun 30, 2023 | -8,614.00 |
| Mar 31, 2023 | -36,105.00 |
| Dec 31, 2022 | 7,367.00 |
| Sep 30, 2022 | 8,647.00 |
| Jun 30, 2022 | -26,387.00 |
| Mar 31, 2022 | 5,975.00 |
| Dec 31, 2021 | 176,584.00 |
| Sep 30, 2021 | -17,047.00 |
| Jun 30, 2021 | -53,147.00 |